Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open.
The consensus EPS Estimate is $1.87 (-5.1% Y/Y) and the consensus Revenue Estimate is $20.83B (+2.2% Y/Y).
Over the last 2 years, JNJ has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 2 upward revisions and 3 downward. Revenue estimates have seen 5 upward revisions and 0 downward.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.